Amrize Ltd $AMRZ Stock: Vontobel Holding Ltd. Lowers Stake

Vontobel Holding Ltd. trimmed its holdings in Amrize Ltd (NYSE:AMRZ) by 7.3% during the third quarter, Holdings Channel reports. The firm owned 4,447,467 shares of the company’s stock after selling 348,602 shares during the quarter. Vontobel Holding Ltd.’s holdings in Amrize were worth $166,965,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Peddock Capital Advisors LLC raised its holdings in Amrize by 3.9% during the third quarter. Peddock Capital Advisors LLC now owns 21,017 shares of the company’s stock worth $786,000 after buying an additional 790 shares during the last quarter. Allied Investment Advisors LLC boosted its holdings in Amrize by 10.1% in the 3rd quarter. Allied Investment Advisors LLC now owns 264,812 shares of the company’s stock worth $9,901,000 after buying an additional 24,363 shares during the period. HF Advisory Group LLC raised its stake in shares of Amrize by 31.1% during the 3rd quarter. HF Advisory Group LLC now owns 27,958 shares of the company’s stock valued at $1,045,000 after purchasing an additional 6,633 shares during the period. Grove Bank & Trust grew its stake in Amrize by 2.1% during the third quarter. Grove Bank & Trust now owns 17,477 shares of the company’s stock valued at $653,000 after acquiring an additional 353 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its stake in Amrize by 3.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 14,506 shares of the company’s stock worth $542,000 after acquiring an additional 543 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts have commented on AMRZ shares. Weiss Ratings cut shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, October 8th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Amrize from $64.00 to $56.00 and set a “buy” rating for the company in a research note on Wednesday, September 23rd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $60.00 price target on shares of Amrize in a research report on Monday, September 21st. Barclays initiated coverage on shares of Amrize in a research report on Thursday, October 1st. They set an “equal weight” rating and a $55.00 price objective on the stock. Finally, UBS Group cut their target price on shares of Amrize from $57.00 to $42.00 and set a “neutral” rating on the stock in a research note on Tuesday, September 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, Amrize presently has a consensus rating of “Hold” and a consensus target price of $50.00.

Insider Buying and Selling at Amrize

In other news, Director Jacques Sanche acquired 4,150 shares of Amrize stock in a transaction on Wednesday, August 26th. The shares were bought at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the acquisition, the director directly owned 9,766 shares of the company’s stock, valued at $439,665.32. This trade represents a 73.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Jan Jenisch acquired 4,000 shares of Amrize stock in a transaction that occurred on Wednesday, September 2nd. The stock was acquired at an average cost of $42.50 per share, with a total value of $170,000.00. Following the purchase, the chief executive officer directly owned 519,000 shares of the company’s stock, valued at $22,057,500. This represents a 0.78% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders bought 48,983 shares of company stock valued at $2,158,755. Corporate insiders own 0.54% of the company’s stock.

Amrize Stock Performance

AMRZ stock traded up $0.54 during trading on Friday, reaching $37.85. The stock had a trading volume of 4,542,880 shares, compared to its average volume of 3,589,370. Amrize Ltd has a 52 week low of $35.78 and a 52 week high of $65.94. The firm has a market cap of $20.94 billion, a PE ratio of 17.44, a PEG ratio of 1.32 and a beta of 0.20. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The stock’s 50 day moving average is $40.94 and its two-hundred day moving average is $48.83.

Amrize (NYSE:AMRZ) last released its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $3.49 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. As a group, equities analysts anticipate that Amrize Ltd will post 2.44 earnings per share for the current year.

Amrize Announces Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is 5.07%.

Amrize Profile

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.